These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37163946)

  • 1. Discovery of 2,5-diaminopyrimidine derivatives as the first series of selective monomeric degraders of B-lymphoid tyrosine kinase.
    Fu T; Zuo Y; Xue G; Zhou D; Pan Z
    Eur J Med Chem; 2023 Aug; 256():115460. PubMed ID: 37163946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of selective irreversible inhibitors of B-Lymphoid tyrosine kinase (BLK).
    Fu T; Zuo Y; Zhong Z; Chen X; Pan Z
    Eur J Med Chem; 2022 Feb; 229():114051. PubMed ID: 34952433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.
    Compeer EB; Janssen W; van Royen-Kerkhof A; van Gijn M; van Montfrans JM; Boes M
    Oncotarget; 2015 May; 6(13):10759-71. PubMed ID: 25926555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines.
    Fallacara AL; Passannanti R; Mori M; Iovenitti G; Musumeci F; Greco C; Crespan E; Kissova M; Maga G; Tarantelli C; Spriano F; Gaudio E; Bertoni F; Botta M; Schenone S
    Eur J Med Chem; 2019 Nov; 181():111545. PubMed ID: 31400706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel BLK-induced tumor model.
    Petersen DL; Berthelsen J; Willerslev-Olsen A; Fredholm S; Dabelsteen S; Bonefeld CM; Geisler C; Woetmann A
    Tumour Biol; 2017 Jul; 39(7):1010428317714196. PubMed ID: 28670978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of protein tyrosine kinases in the Ig complex of anti-mu-sensitive and anti-mu-resistant B-cell lymphomas: role of the p55blk kinase in signaling growth arrest and apoptosis.
    Yao XR; Scott DW
    Immunol Rev; 1993 Apr; 132():163-86. PubMed ID: 8349295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.
    Dymecki SM; Niederhuber JE; Desiderio SV
    Science; 1990 Jan; 247(4940):332-6. PubMed ID: 2404338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
    Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
    Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma.
    Yao XR; Scott DW
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7946-50. PubMed ID: 7690139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of the B cell antigen receptor signaling components in COS cells.
    Saouaf SJ; Kut SA; Fargnoli J; Rowley RB; Bolen JB; Mahajan S
    J Biol Chem; 1995 Nov; 270(45):27072-8. PubMed ID: 7592958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinase-independent potentiation of B cell antigen receptor-mediated signal transduction by the protein tyrosine kinase Src.
    Lin J; Tao J; Dyer RB; Herzog NK; Justement LB
    J Immunol; 1997 Nov; 159(10):4823-33. PubMed ID: 9366407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH2 domains of the protein-tyrosine kinases Blk, Lyn, and Fyn(T) bind distinct sets of phosphoproteins from B lymphocytes.
    Malek SN; Desiderio S
    J Biol Chem; 1993 Oct; 268(30):22557-65. PubMed ID: 8226767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of syk in an immature B cell line does not require lyn activity.
    Muthukkumar S; Venkataraman C; Woods T; Bondada S
    Mol Immunol; 1997; 34(12-13):865-75. PubMed ID: 9464522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SH2 domains of Src family kinases associate with Syk.
    Aoki Y; Kim YT; Stillwell R; Kim TJ; Pillai S
    J Biol Chem; 1995 Jun; 270(26):15658-63. PubMed ID: 7797565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.
    Malek SN; Dordai DI; Reim J; Dintzis H; Desiderio S
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7351-6. PubMed ID: 9636152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk.
    Tretter T; Ross AE; Dordai DI; Desiderio S
    J Exp Med; 2003 Dec; 198(12):1863-73. PubMed ID: 14662906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein.
    Zwollo P; Desiderio S
    J Biol Chem; 1994 May; 269(21):15310-7. PubMed ID: 8195169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occurs in response to antigen-receptor ligation in B cells and constitutively in pre-B cells.
    Aoki Y; Isselbacher KJ; Cherayil BJ; Pillai S
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4204-8. PubMed ID: 7514299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk.
    Dymecki SM; Zwollo P; Zeller K; Kuhajda FP; Desiderio SV
    J Biol Chem; 1992 Mar; 267(7):4815-23. PubMed ID: 1537861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.